Paper7227366
Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.
Chou TC and 1 other. Eur J Biochem, 1981. Cited by 370 papers, by iCite.
Cite this record
ConductScience Library. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors. Papers, record 7227366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7227366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Enzyme Inhibitors | Major topic |
| Kinetics | |
| Mathematics | |
| Models, Biological |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AM 07422 | NIADDK NIH HHS | United States | PubMed | PubMed | |
| CA 27569 | NCI NIH HHS | United States | R01CA027569 | PubMed and NIH | NIH RePORTER |
| GM 16492 | NIGMS NIH HHS | United States | PubMed | PubMed |
Cited by173
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 370 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42003968 | Eprenetapopt in combination with carboplatin in high-grade ovarian and triple negative breast cancer cell lines with acquired resistance to olaparib. | Front Oncol | 2026 | https://conductscience.org/library/papers/42003968 | PubMed |
| 41027874 | Challenges to determine synergistic drug interactions in mice. | Nat Commun | 2025 | https://conductscience.org/library/papers/41027874 | PubMed |
| 40341222 | Synergistic effects of abietic acid combined with doxorubicin on apoptosis induction in a human colorectal cancer cell line. | Sci Rep | 2025 | https://conductscience.org/library/papers/40341222 | PubMed |
| 39802605 | Gossypol enhances ponatinib's cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT/LC3II/p62, and Bcl2/caspase-3 pathways. | Toxicol Rep | 2025 | https://conductscience.org/library/papers/39802605 | PubMed |
| 39791794 | Multifunctional Nanoparticles as Radiosensitizers to Overcome Hypoxia-Associated Resistance in Cancer Radiotherapy. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39791794 | PubMed |
| 39627385 | Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/39627385 | PubMed |
| 39456799 | Synergistic Proliferation Effects of Xanthohumol and Niflumic Acid on Merkel and Glioblastoma Cancer Cells: Role of Cell Membrane Interactions. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39456799 | PubMed |
| 38236451 | Synergistic effect of a nonsteroidal anti-inflammatory drug in combination with topotecan on small cell lung cancer cells. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38236451 | PubMed |
| 38132957 | The Salmon Oil OmeGo Reduces Viability of Colorectal Cancer Cells and Potentiates the Anti-Cancer Effect of 5-FU. | Mar Drugs | 2023 | https://conductscience.org/library/papers/38132957 | PubMed |
| 37232374 | Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer. | Oncol Rep | 2023 | https://conductscience.org/library/papers/37232374 | PubMed |
| 37121274 | High-throughput approaches to uncover synergistic drug combinations in leukemia. | SLAS Discov | 2023 | https://conductscience.org/library/papers/37121274 | PubMed |
| 36662193 | Gold Nanoparticles Synthesized by an Aqueous Extract of Codium tomentosum as Potential Antitumoral Enhancers of Gemcitabine. | Mar Drugs | 2022 | https://conductscience.org/library/papers/36662193 | PubMed |
| 36185647 | A network pharmacology approach to evaluate the synergistic effect of dihydromyricetin and myricitrin in vine tea on the proliferation of B16F10 cells. | Front Nutr | 2022 | https://conductscience.org/library/papers/36185647 | PubMed |
| 35986755 | Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones. | Arch Toxicol | 2022 | https://conductscience.org/library/papers/35986755 | PubMed |
| 35983428 | Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35983428 | PubMed |
| 35890123 | Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890123 | PubMed |
| 35440025 | CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35440025 | PubMed |
| 34991440 | Non-parametric synergy modeling of chemical compounds with Gaussian processes. | BMC Bioinformatics | 2022 | https://conductscience.org/library/papers/34991440 | PubMed |
| 34637097 | Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil. | Mol Biol Rep | 2021 | https://conductscience.org/library/papers/34637097 | PubMed |
| 34386644 | Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells. | Dev Reprod | 2021 | https://conductscience.org/library/papers/34386644 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7227366
GET https://conductscience.org/api/papers/v1/7227366/cited_by?page=2